Want to see TSE:CLC full AI Analyst Report?
Top Page
Christina Lake Cannabis
(CLC)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.03
▲(70.00% Upside)
Action:Reiterated
Date:10/16/26
The score is held down primarily by deteriorating financial performance—TTM revenue and margins weakened sharply, profitability turned negative, and free cash flow is currently negative. Technicals are a partial offset with price strength above key moving averages and a positive MACD, but elevated RSI signals an overextended move. Valuation is also constrained by current losses (negative P/E) and the absence of a dividend yield.
Positive Factors
Positive equity base
Positive equity and a meaningful asset base provide a solvency cushion as the company works through weaker earnings. This supports continued operations and gives management more flexibility than a balance sheet already impaired by accumulated losses, although current profitability remains a concern.
Negative Factors
Revenue and profit reversal
The latest TTM period shows a severe deterioration in the income statement, with lower revenue accompanied by negative gross profit and a sizable net loss. This weakens earnings visibility, raises questions about cost structure and pricing, and could limit internally funded growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive equity base
Positive equity and a meaningful asset base provide a solvency cushion as the company works through weaker earnings. This supports continued operations and gives management more flexibility than a balance sheet already impaired by accumulated losses, although current profitability remains a concern.
Read all positive factors
Christina Lake Cannabis (CLC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.20M
Dividend YieldN/A
Average Volume (3M)30.22K
Price to Earnings (P/E)―
Beta (1Y)-0.21
Revenue Growth-18.09%
EPS Growth-248.08%
CountryCA
Employees8
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding248,093,570
10 Day Avg. Volume46,330
30 Day Avg. Volume30,218
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.48
Price to Sales (P/S)0.53
P/FCF Ratio1.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Christina Lake Cannabis Business Overview & Revenue Model
Company Description
Operating out of British Columbia, Canada, Christina Lake Cannabis Corp. is engaged in the cultivation, processing, and distribution of a variety of cannabis products. Its portfolio features cannabis oil, hemp oil, other cannabis and hemp derivati...
Christina Lake Cannabis Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
55
Neutral
Cash Flow
24
Negative
| Breakdown | TTM | Nov 2025 | Nov 2024 | May 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.23M | 15.08M | 13.61M | 11.78M | 10.07M | 3.63M |
| Gross Profit | -2.32M | 1.94M | 9.31M | 3.61M | 2.98M | 56.72K |
| EBITDA | 63.56K | 2.92M | 3.25M | -2.62M | -938.92K | -5.97M |
| Net Income | -4.03M | 1.10M | 865.00K | -4.13M | -1.74M | -6.78M |
Balance Sheet | ||||||
| Total Assets | 19.22M | 28.02M | 23.37M | 15.96M | 18.79M | 18.97M |
| Cash, Cash Equivalents and Short-Term Investments | 1.68M | 1.67M | 1.85M | 1.47M | 1.84M | 1.08M |
| Total Debt | 7.78M | 8.74M | 10.27M | 6.15M | 6.45M | 3.81M |
| Total Liabilities | 9.97M | 11.18M | 12.57M | 8.50M | 7.66M | 9.23M |
| Stockholders Equity | 9.25M | 16.84M | 10.79M | 7.46M | 11.14M | 9.74M |
Cash Flow | ||||||
| Free Cash Flow | -1.02M | 4.68M | -4.13M | 781.46K | 394.55K | -5.85M |
| Operating Cash Flow | 97.79K | 2.68M | 221.02K | 1.38M | 1.18M | -4.62M |
| Investing Cash Flow | -513.36K | 2.19M | -4.47M | -571.37K | -790.41K | -1.20M |
| Financing Cash Flow | -1.30M | -5.06M | 4.59M | -1.15M | 369.17K | 5.06M |
Christina Lake Cannabis Technical Analysis
Negative
0.02
Price Trends
0.03
Negative
0.03
Negative
0.03
Negative
Market Momentum
>-0.01
Positive
42.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.37 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CLC.
Christina Lake Cannabis Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$3.40M | -1.75 | -43.92% | ― | -18.30% | -397.37% | |
46 Neutral | C$8.15M | -0.67 | -43.60% | ― | -15.88% | 59.93% | |
45 Neutral | C$5.21M | 6.25 | -11.60% | ― | -4.90% | ― | |
45 Neutral | C$7.43M | -7.14 | -332.63% | ― | -36.67% | 40.54% | |
43 Neutral | C$6.20M | -1.62 | -31.36% | ― | -18.09% | -248.08% |
* Healthcare Sector Average
TSE:CLC
Christina Lake Cannabis
0.03
-0.02
-37.50%
TSE:TGIF
1933 Industries
0.01
0.00
0.00%
TSE:BBM
Blueberries Medical
0.02
>-0.01
-25.00%
TSE:AVNT
Avant Brands
0.53
-0.05
-8.62%
TSE:OILS
Nextleaf Solutions
0.02
-0.04
-66.67%
TSE:HASH
Simply Solventless Concentrates Ltd
0.05
-0.22
-82.69%
Christina Lake Cannabis Corporate Events
Business Operations and StrategyM&A Transactions
Christina Lake Cannabis Enters Talks on $15 Million Takeover
Positive
Aug 21, 2026
Christina Lake Cannabis has signed a non-binding letter of intent with a private Alberta corporation that contemplates the acquisition of all its outstanding common shares. The proposed deal assigns an aggregate transaction value of $15 million on...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.